Sedating patients undergoing mechanical ventilation in the intensive care unit--winds of change?
K. Kong,J. Bion
DOI: https://doi.org/10.1093/BJA/AEG066
IF: 11.719
2003-03-01
British Journal of Anaesthesia
Abstract:The majority of mechanically ventilated patients in the intensive care unit (ICU) require sedation to reduce anxiety, encourage sleep and to increase tolerance to tracheal tubes and the ventilator. Sedative and analgesic drugs are amongst the most commonly prescribed medications in the ICU. The choice of agent and the way in which they are used varies widely between and within ICUs. In a survey of 164 ICUs in the US, 18 different sedative agents were used, the commonest of which were the opiates and benzodiazepines. A more recent study revealed substantial differences in the clinical use of drugs for sedation and analgesia in the western European countries surveyed. These differences in clinical practice can have an important impact on patient outcome and cost of care: excessively deep sedation will prolong ventilator dependence and length of stay in the ICU, which can be avoided by careful monitoring and interruption of sedative infusions. 5 But failure to provide appropriate sedation and analgesia may add to the well-recognised psychological burden of critical illness for patients, 7 and indirectly for relatives. The appropriate use of sedative drugs is an important process measure of quality of care. But to tread the ®ne line between adequate comfort and avoidance of excessive sedation demands both the use of clinically relevant sedation scales, 10 and the availability of more `responsive' sedative agents. The volatile anaesthetic agents offer considerable potential in this respect. In this issue of the journal, Meiser and colleagues report the use of the inhalation anaesthetic des ̄urane and compare it with propofol for postoperative sedation in the ICU. Inhalation anaesthetic agents have been used for sedation for many years. Sir Humphry Davy ®rst suggested that nitrous oxide inhalation could be used to provide analgesia and sedation during surgical operations more than 200 years ago. In the 1960s, using nitrous oxide in a technique called `relative analgesia', Langa demonstrated that by increasing inspired concentrations of nitrous oxide, an increasing depth of sedation could be achieved. Guedel certainly described the ®rst stage of surgical anaesthesia in terms of deepening levels of sedation. Therefore, in sub-anaesthetic concentrations, inhalation anaesthetics can be used to achieve easily modi®able levels of sedation, which may allow contact with family and attendants while facilitating cooperation with therapeutic interventions. Until recently, the most promising agent in this respect was iso ̄urane. With its low blood solubility and minimal metabolism, iso ̄urane, when compared with midazolam, 15 and propofol, was shown to provide safe and effective sedation in mechanically ventilated patients with a range of severity of illness. However, despite its advantages, iso ̄urane has not gained acceptance as a sedative in the ICU, probably because of the lack of convenient equipment for administering and scavenging it, and unresolved concern about potential ̄uoride ion nephrotoxicity with prolonged administration. Inhalation agents may be advantageous when used for sedation of mechanically ventilated patients in the ICU for many reasons. Inhalation is a dependable route of drug administration and elimination. Drugs administered via this route generally have a rapid onset of action and the recovery period is short. I.V. sedatives have a ̄atter dose±response curve than do the inhalation anaesthetics, and the range of blood concentrations and their consequent effects is greater. The steeper dose±response curve with inhalation anaesthetics indicates a more consistent time to the onset of sedation and less variability in the doses required. In clinical practice, this would facilitate easy adjustment of dose to the desired sedative effect. Many critically ill patients have impaired hepatic and/or renal function. I.V. sedatives that depend on liver metabolism or renal excretion for elimination all have cumulative or prolonged effects. In contrast, recovery from inhalation agents that are administered and excreted through the lungs is both rapid and predictable. Any adverse effects arising from an overdose of an inhalation sedative can be reversed rapidly by reducing the inspired concentration. Inhalation anaesthetics are also useful in facilitating treatment procedures in the ICU, such as bronchoscopy, insertion of chest drains and invasive monitoring procedures. The desired level of sedation can be titrated rapidly, ranging from a light level to that approaching a general anaesthetic. It is also `̀ I would have everie man write what he knowes and no more.''ÐMontaigne